Qiang Li, Deyuan Zhu, Nan Lv, Pengfei Yang, Yu Zhou, Rui Zhao, Wenjin Yang, Ming Lv, Tianxiao Li, Wenyuan Zhao, Tiewei Qi, Weixi Jiang, Chuanzhi Duan, Guangyu Zhao, Guoli Duan, Yina Wu, Qian Zheng, Zifu Li, Qiao Zuo, Dongwei Dai, Yibin Fang, Qinghai Huang, Bo Hong, Yi Xu, Yuxiang Gu, Sheng Guan, Jianmin Liu
PURPOSE: In China, the application of nitinol Tubridge flow diverter (TFD) has become popular for treating intracranial aneurysms (IAs). In this study, we investigated the safety outcomes of the application of TFD for treating IAs in real-world scenarios. METHODS: We retrospectively analyzed aneurysms treated with TFD in 235 centers throughout China between April 2018 and April 2020. The primary endpoint was the event-free survival rate at 12 months, defined as the occurrence of morbidity (spontaneous rupture, intraparenchymal hemorrhage (IPH), ischemic stroke, and permanent cranial neuropathy) or death...
February 15, 2024: Clinical Neuroradiology